Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Lipocine (LPCN)
NASDAQ:LPCN
Lipocine (LPCN) Stock Price & Analysis
842 Followers
LPCN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.30 - $15.64
Previous Close$4.46
Volume25.74K
Average Volume (3M)28.43K
Market Cap
$23.22M
Enterprise Value-$5.65M
Total Cash (Recent Filing)$28.87M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-2.1
Beta0.58
Next Earnings
Aug 09, 2023EPS Estimate
-$0.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.16
Shares Outstanding88,510,791
10 Day Avg. Volume23,339
30 Day Avg. Volume28,434
Standard Deviation0.23
R-Squared0.05
Alpha0.00060
Financial Highlights & Ratios
Price to Book (P/B)12.66
Price to Sales (P/S)7177.42
Price to Cash Flow (P/CF)-25.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-10.18
Enterprise Value/Gross Profit-11.30
Enterprise Value/Ebitda0.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lipocine News
Pre-EarningsLPCN Upcoming Earnings Report: What to Expect?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LPCN FAQ
What was Lipocine’s price range in the past 12 months?
Lipocine lowest stock price was $3.30 and its highest was $15.64 in the past 12 months.
What is Lipocine’s market cap?
Currently, no data Available
When is Lipocine’s upcoming earnings report date?
Lipocine’s upcoming earnings report date is Aug 09, 2023 which is in 62 days.
How were Lipocine’s earnings last quarter?
Lipocine released its earnings results on May 11, 2023. The company reported -$0.68 earnings per share for the quarter, missing the consensus estimate of -$0.425 by -$0.255.
Is Lipocine overvalued?
According to Wall Street analysts Lipocine’s price is currently Overvalued.
Does Lipocine pay dividends?
Lipocine does not currently pay dividends.
What is Lipocine’s EPS estimate?
Lipocine’s EPS estimate is -$0.64.
How many shares outstanding does Lipocine have?
Lipocine has 5,206,517 shares outstanding.
What happened to Lipocine’s price movement after its last earnings report?
Lipocine reported an EPS of -$0.68 in its last earnings report, missing expectations of -$0.425. Following the earnings report the stock price went up 7.08%.
Which hedge fund is a major shareholder of Lipocine?
Currently, no hedge funds are holding shares in LPCN
---
Lipocine Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $109.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.61%
12-Months-Change
Fundamentals
Return on Equity
-29.96%
Trailing 12-Months
Asset Growth
-28.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Lipocine
Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.
---
Top 5 ETFs holding LPCN
iShares Core S&P Total U.S. Stock Market ETF
$31.22
Up to five ETFs with an Outperform Smart Score that hold LPCN. The ETFs are listed according to market value of LPCN within the ETF
---
Intra-Cellular Therapies
―
Eton Pharmaceuticals
―
Kala Pharmaceuticals
―
Cassava Sciences
―
---